- Dr. Denise Galloway and colleagues laid the groundwork for development of Gardasil and Cervarix, the two vaccines that have been found to prevent HPV infection in women. Gardasil, approved for use in the United States by the Food and Drug Administration in 2006, prevents HPV types 16 and 18, which account for 70 percent of cervical cancers, and HPV types 6 and 11, which cause 90 percent of genital warts. Cervarix is licensed for use in Europe. Galloway, along with researchers in Australia and at the National Institutes of Health, accomplished the critical step of getting a key viral gene to assemble into particles that look like HPV, forming the basis of today's vaccine. Learn more »Source : http://www.fhcrc.org/content/public/en/diseases/cervical-cancer.html
Hiç yorum yok:
Yorum Gönder